Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Thrombosis 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Metabolic Diseases 1Hematologic Neoplasms 1Catheter-Related Infections 1Bacteremia 1Anemia, Aplastic 1

Interventions

bemiparin 1X-Rays 1Tinzaparin 1Technetium Tc 99m Sulfur Colloid 1Photons 1Phlebotomy 1Hydroxyurea 1Heparin, Low-Molecular-Weight 1Heparin 1Enoxaparin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thrombosis × Heparin × Clear all
NCT01820962 2013-03-29

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Maastricht University Medical Center

Phase 3 Terminated
212 enrolled
Other hematologic neoplasm

Thrombosis, Bacteremia, Hematologic Neoplasms, Catheter-Related Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡